Research funding opportunities

Coeliac UK in collaboration with Innovate UK are launching a second research call to industry and researchers to make improvements for people living with coeliac disease. Research must focus on either: improving diagnostics for coeliac disease, refractory coeliac disease and/or gluten related neurological conditions; developing tools for improving the long term management of coeliac disease; enhancing the quality of staple gluten free food.

Coeliac UK in collaboration with Innovate UK are launching a second research call to industry and researchers to make improvements for people living with coeliac disease. Research must focus on either: improving diagnostics for coeliac disease, refractory coeliac disease and/or gluten related neurological conditions; developing tools for improving the long term management of coeliac disease; enhancing the quality of staple gluten free food.

Coeliac UK in collaboration with Innovate UK are launching a second research call to industry and researchers to make improvements for people living with coeliac disease. Research must focus on either: improving diagnostics for coeliac disease, refractory coeliac disease and/or gluten related neurological conditions; developing tools for improving the long term management of coeliac disease; enhancing the quality of staple gluten free food.

Open to researchers who have already been awarded an ERC grant. This will be additional funding to establish the innovation potential of ideas arising from the ERC-funded research projects.

GOSH Charity and LifeArc are inviting translational, milestone-driven applications which aim to improve the prevention, diagnosis, prognosis, or treatment of rare disease or that focus on developing research tools that increase the efficiency of developing interventions in rare disease. The scheme is designed to support applications on the translational pathway with the expectation that researchers will continue to develop their therapy/ diagnostic after GOSH charity/LifeArc funding, either by s...

Funds translational research that will lead to major advances in medical treatment. Priority will be projects addressing a key clinical need and have a good chance of being developed further towards clinical translation and patient benefit.

Funds tenured and non-tenured researchers, clinicians and non-clinicians to undertake high quality biomedical research and has no priority diseases or restrictions on the research area supported.